This advisory highlights more than 100 poster abstracts that will be presented at ASH 2025 involving researchers ...
Immix Biopharma, Inc. is building strength in its pipeline with impressive early signals in AL amyloidosis. Learn more about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback